FIELD: pharmaceutics; medicine.
SUBSTANCE: group of inventions relates to the field of pharmaceutics and medicine; it is aimed at the treatment of tendinopathy. In particular, methods for the treatment of tendinopathy are described, including the injection to a subject of therapeutically effective number of compounds with structural Formulas I and Ia (values of radicals are such as specified in the formula of the invention), as well as a number of individual compounds or their pharmaceutically acceptable salts.
EFFECT: effective treatment of tendinopathy.
36 cl, 11 dwg, 9 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INDAZOLE-3-CARBOXAMIDES AND THEIR USE AS WNT/β-CATENIN SIGNAL INHIBITORS | 2012 |
|
RU2627693C2 |
| ANILIDES OF AMINO ACIDS AS LOW-MOLECULAR MODULATORS IL-17 | 2019 |
|
RU2815505C2 |
| HETEROCYCLIC MAT2A INHIBITORS AND METHODS OF THEIR USE FOR CANCER TREATMENT | 2019 |
|
RU2809987C2 |
| 1H-PYRAZOLO[3,4-B]PYRIDINES AND THEIR THERAPEUTIC APPLICATIONS | 2013 |
|
RU2689141C2 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2014 |
|
RU2681849C2 |
| INDAZOLIE WNT SIGNAL PATHWAY INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS | 2017 |
|
RU2682245C1 |
| 6-5 CONDENSED RINGS AS C5a INHIBITORS | 2018 |
|
RU2780338C2 |
| INDASOLE INHIBITORS OF Wnt SIGNAL PATH AND THEIR THERAPEUTIC APPLICATIONS | 2013 |
|
RU2638932C2 |
| SUBSTITUTED CHROMANS | 2015 |
|
RU2718060C2 |
| COMPOUNDS FOR THE TREATMENT OF CERTAIN LEUKOSIS | 2019 |
|
RU2804709C2 |
